Effect of Shirodhara on mental disease after Covid
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2022/06/043444
- Lead Sponsor
- ALL INDIA INSTITUTE OF AYRVEDA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Aged between 18 to 60 years
2.Having developed COVID positive status
3.Diagnosed as having major depressive and generalized anxiety disorder by a psychiatrist (co-supervisor) as per diagnostic criteria listed in DSM-5
4. Currently receiving treatment (Fluoxetine and or Clonazepam) and planning to pursue follow up psychiatry care for next 1 month at study center.
5.Able to understand Hindi/English
6.Medically stable to participate in Shirdohara intervention as assessed by treating psychiatrist on medical examination.
1.Past history of psychiatric illness prior to developing COVID .
2.Reporting presence of suicidal thoughts/ideation or attempts within last 2 weeks.
3.Already on any alternative form of therapy besides standard pharmacotherapy and or psychotherapy for depression
4.Having history suggestive of being diagnosed any medical condition requiring hospitalization currently or in recent past 6 weeks making participation in Shirodhara based program difficult
5.The patient having symptoms like cough, sneezing, running nose currently making participation in Shirodhara based program difficult
6.Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Evaluate the efficacy of Shirodhara on mental health disorders <br/ ><br>2.Assessment of effect of Shirodhara on selected biomarkers viz. Sr. Cortisol, Lipid profile, CRP, <br/ ><br>Timepoint: Day 1 Day 8 Day 15 and Day 30
- Secondary Outcome Measures
Name Time Method 1.Assessment of the quality of lifeTimepoint: Day 1 Day 8 Day 15 and Day 30